Camelina Oil.
It's a seed oil rich in alpha-linolenic acid, the plant omega-3 your body cannot make. It tops up omega-3 intake from a field crop rather than a fish.
Reviewed March 2026
- Category
- Fatty acid
What Camelina Oil is, and what it does.
- Does it work
- Suits people who rarely eat oily fish and plant-based eaters after an omega-3 source. If you already take a marine oil, this covers the plant side of the family.
- How much to take
- Start with 1,000mg to 3,000mg a day, which is where the oil earns its keep as a daily omega-3 top-up. Take it with a meal that contains some fat.
- Time to feel it
- Nothing acute. Blood levels of the plant omega-3 shift across roughly four to twelve weeks of daily use, which is where the change is read.
- The first dose
- Day one is a nutty, grassy oil or a softgel with food. Nothing registers yet, because the omega-3 side is read on blood fatty acid levels across weeks.
- With regular use
- Weeks of daily use raise circulating alpha-linolenic acid and, more slowly, EPA. Blood lipid panels are where trials have looked for the effect.
- How well tolerated
- Well tolerated as a food oil. Higher amounts can bring burping or looser stools. Check with your clinician if you take blood thinning medicines, and keep the bottle cool and dark.
- How it feels
- Little in the way of sensation. Neat oil tastes nutty and grassy, and softgels skip the taste entirely.
- The overlooked benefit
- It carries a lot of its own gamma-tocopherol, a vitamin E form that helps the oil resist going off without anything added.
1,000 to 3,000mg a day is where Camelina Oil works.
Source: Karvonen et al. (2002) Eur J Clin Nutr; camelina omega-3 ALA content
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Camelina Oil has emerging evidence. Based on 408+ studies.
- alpha-linolenic acid status in bloodRandomised trial
- blood lipid measures already in the normal rangeRandomised trial
- conversion of plant omega-3 to EPARandomised trial
- essential fatty acid intake in people not eating oily fishNarrative review
- oxidative stability from native tocopherol contentIn vitro study
Questions people ask about Camelina Oil.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Camelina oil is rich in alpha-linolenic acid and other polyunsaturated chains that oxidise readily. Tocopherol, which the oil also carries natively, is the standard protector added with it.
Human conversion of alpha-linolenic acid to EPA is limited and conversion to DHA lower still. Preformed EPA and DHA cover the end of the chain camelina cannot reliably reach.
Camelina supplies the short-chain omega-3 while algal oil supplies DHA directly. Together they cover the plant omega-3 profile end to end.
Both are alpha-linolenic acid oils drawing on the same conversion route, so their doses add rather than complement. Camelina carries a higher tocopherol load and a different omega-6 balance.
Delta-6 desaturase, the enzyme that starts alpha-linolenic acid down the long-chain route, depends on zinc. Status here changes how much conversion the dose actually yields.
Alpha-linolenic acid from camelina oil and linoleic acid from seed oils compete for the same delta-6 desaturase enzyme that starts the conversion to longer-chain fatty acids. A diet heavy in linoleic acid lowers the fraction of ALA that gets converted. This is one of the better-established anti-synergies in fatty acid nutrition.
The desaturase and elongase steps that lengthen alpha-linolenic acid depend on a set of nutrient cofactors that includes pyridoxine alongside zinc and magnesium. Shortfall in any of them slows the conversion route. This is a background requirement, not a claim that B6 raises omega-3 status on its own.
Elongase steps in fatty acid metabolism are ATP-dependent and run on magnesium-complexed nucleotide. Adequate magnesium is part of the machinery that converts plant omega-3 into longer-chain forms. Stated as a cofactor relationship rather than a measured effect.
Polyunsaturated oils depend on tocopherol to intercept lipid radicals, and ascorbate regenerates the tocopheroxyl radical back to tocopherol. That recycling loop is why vitamin C is relevant to anyone taking a high-PUFA oil. It protects the oil's own antioxidant rather than the oil directly.
Rosemary extract carnosic acid and rosmarinic acid are standard natural antioxidants added to polyunsaturated oils to slow peroxide formation during storage. Camelina oil's high alpha-linolenic content makes it a candidate for this treatment. The relationship is about keeping the oil intact, not about a biological effect in the body.
Camelina oil supplies alpha-linolenic acid, which the body converts to EPA at a low and variable rate. Preformed EPA bypasses that bottleneck entirely, so the two supply the same downstream pool by different routes. Transgenic camelina lines carrying EPA directly have been studied in animals for exactly this reason.
Conversion of alpha-linolenic acid onward to DHA is the least efficient step in the pathway in humans. A DHA source therefore covers the part of the omega-3 family that plant oil supplies least well. The two are complementary rather than interchangeable.
Triglyceride oils need bile salt emulsification and pancreatic lipase before the fatty acids can be absorbed. Reduced bile flow lowers uptake of any dietary oil, camelina included. This is standard digestive physiology rather than a specific finding about camelina.
Pancreatic lipase cleaves the fatty acids from the glycerol backbone, which is the required step before absorption. Supplemental lipase is used where pancreatic output is low. It acts on the oil, not with it.
Evening primrose oil is dominated by linoleic acid and gamma-linolenic acid, which occupy the same desaturase and elongase enzymes that alpha-linolenic acid needs. Taking generous amounts of both shifts the balance of the enzyme's output. Worth flagging when the goal is raising omega-3 status specifically.
A dietary oil provides the lipid phase that fat-soluble vitamins need for micelle formation and absorption. Taking cholecalciferol alongside an oil dose is a straightforward way to meet that requirement. This concerns the vitamin's uptake, not camelina's own actions.
Nothing specific on file for Camelina Oil. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Camelina Oil actually does.
Camelina sativa seed oil is unusually rich in alpha-linolenic acid, the 18-carbon plant omega-3, and also carries appreciable linoleic acid and the 20-carbon monounsaturate gondoic acid.
Alpha-linolenic acid is an essential fatty acid: humans cannot introduce a double bond beyond carbon 9 counting from the methyl end, so the omega-3 family has to come from the diet.
Conversion of alpha-linolenic acid to EPA runs through delta-6 desaturase, elongase and delta-5 desaturase, and the further step to DHA is inefficient in humans, so a plant oil and a marine oil are not interchangeable sources.
Because it is highly polyunsaturated, camelina oil oxidises readily on exposure to heat, light and air, which is why it is typically cold-pressed, stored dark and cool, and protected with tocopherols.
Where Camelina Oil comes from.
The seed gets crushed and the oil comes out. Some producers stop there and bottle it, others clean it up into a neutral oil for capsules. Either way it is a delicate oil, so dark glass, a cool cupboard and a use-by date matter more than they would for a bland cooking oil.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A short-season brassica oilseed, also called false flax or gold-of-pleasure, grown on relatively low input and often as a rotation or cover crop.
Seed is cleaned of chaff and stones, then crushed in a screw press. Cold pressing keeps temperatures down and leaves an oil-rich press cake behind.
Where yield matters more than a cold-pressed designation, residual oil is recovered from the cake with hexane and the solvent is then stripped. This route yields more oil per tonne of seed and changes the minor-component profile.
Unrefined oil is simply settled and filtered. Refined oil goes through degumming, neutralisation, bleaching and deodorisation, which produces a neutral oil and removes pigments and free fatty acids.
Lots are assayed by gas chromatography for alpha-linolenic, linoleic and gondoic acid content, and by peroxide and anisidine value for oxidation state.
The finished oil is filled under nitrogen into dark bottles, encapsulated in softgels with added tocopherol, or spray-dried into a powder.
Labels often say cold-pressed but rarely state whether the lot was subsequently refined, or what the measured peroxide value was at filling.
Getting Camelina Oil from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A dose-response pooling of the available trials examined how camelina oil supplementation moved blood lipid and glycaemic markers, which are laboratory measures rather than clinical outcomes.Systematic review. Jalili et al., 2022 (Lipids in Health and Disease). PMID 36476379 ↗
- Crackers enriched with camelina sativa oil changed the omega-3 fatty acid composition of serum in the participants, a compositional marker of intake.Randomised trial. De Giuseppe et al., 2023 (The Journal of Nutrition, Health and Aging). PMID 37357331 ↗
- Omega-3-rich camelina sativa oil was assessed against metabolic and clinical markers in adults with elevated liver fat.Randomised trial. Musazadeh et al., 2022 (European Journal of Gastroenterology and Hepatology). PMID 35421019 ↗
- Camelina oil supplementation was tested against measures of vascular function in adults with elevated blood pressure and clustered metabolic risk factors.Randomised trial. Bellien et al., 2022 (The American Journal of Clinical Nutrition). PMID 34791007 ↗
- Co-supplementation of camelina oil with a prebiotic moved cardiometabolic risk markers more than the single supplement arms in this trial.Randomised trial. Kavyani et al., 2021 (Food and Function). PMID 34338703 ↗
- Within a weight loss programme, omega-3-rich camelina sativa oil was associated with changes in glucose homeostasis and inflammatory markers.Randomised trial. Musazadeh et al., 2021 (International Journal of Clinical Practice). PMID 34423525 ↗
- Dietary camelina, flaxseed and canola oils each shifted plasma fatty acid concentrations in the fed animals, with health measures reported alongside.Animal study. Burron et al., 2023 (Animal: An International Journal of Animal Bioscience). PMID 38070473 ↗
- Oil from transgenic camelina sativa carrying EPA and DHA raised those fatty acids in tissue in a non-human feeding model.Animal study. West et al., 2021 (Nutrients). PMID 34578993 ↗
- Seed oil from transgenic camelina sativa produced increments in plasma fatty acid concentrations in this non-human feeding study.Animal study. West et al., 2020 (The British Journal of Nutrition). PMID 32513312 ↗
- Dietary camelina oil was tolerated over the study period in healthy adult dogs, with the monitored clinical chemistry measures reported.Animal study. Burron et al., 2021 (Animals). PMID 34573569 ↗
- Camelina oil supplementation was associated with changes in measured bone parameters in ovariectomised rats, an animal model result.Animal study. Puzio et al., 2021 (Animals). PMID 34065038 ↗
- Camelina seed oil and flaxseed oil produced differing nutritional and metabolic profiles when compared head to head in a rat diet.Animal study. Babu et al., 2025 (Molecules). PMID 40649256 ↗
- Fractionation of camelina cake, the residue left after oil pressing, was characterised for nutritional and functional properties in laboratory analysis.In vitro study. Rakita et al., 2025 (Foods). PMID 41097605 ↗
- A review comparing animal-derived and plant-based oils on oxidative stress and inflammatory markers in ageing, naming camelina among the plant oils considered.Systematic review. Alzunaidy et al., 2025 (Frontiers in Nutrition). PMID 41601899 ↗
These are the studies our verdict leans on, chosen from the 14 we read for Camelina Oil. The full linked list is below.
The studies, linked.
3 sources behind our Camelina Oil verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialThe Effect of Plant Stanol Ester Yoghurt Drinks With or Without Added Camelina Oil on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol ConcentrationsClinicalTrials.gov ↗NA · 155 participants · Completed
- Clinical trialFatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)ClinicalTrials.gov ↗NA · 140 participants · Completed
- Clinical trialRESOLving INflammation Through Diet for Health Multicenter, Prospective Randomized, Controlled and Open- Label to Examine the Impact of a Diet Enriched in Omega 3 Fatty Acids of Animal and Vegetal Origin on Circulating Lipid-driven Pro-/Antiinflammatory Balance in Subjects at Moderate to High Cardiovascular Risk.ClinicalTrials.gov ↗NA · 324 participants · Recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.